Red flags / Going concern

PASGPassage Bio Inc.ElevatedForm 10-Qfiled Nov 10, 7:16 AM ET

Passage Bio flags substantial doubt about going concern as cash may not cover next twelve months

Passage Bio's 10-Q for the period ended September 30, 2026 states that its $20.2 million in cash and cash equivalents may not be sufficient to fund operating and capital expenditure needs for at least the next twelve months. The company reports net losses of $4.7 million for the quarter and $20.1 million for the nine months, and says its ability to continue depends on completing the proposed Merger and related Concurrent Financing or obtaining other substantial funding. Dilution, costly transactions and uncertain financing terms are cited as risks that can weigh on shareholders.

“As a result, substantial doubt exists about our ability to continue as a going concern within one year after the date that the consolidated financial statements are issued.”

What the stock did

From the last close before the filing was public. Market cap now: $13M.

1 day
+10.2%
SPY -0.4%
5 days
+20.4%
SPY -1.7%
20 days
Not yet
 

10-K or 10-Q says there is substantial doubt the company can keep operating. Flags are a screen for filings worth reading, not advice. Read the filing before acting on it.

Other flags on PASG

FiledStockFlagWhat the filing saysMkt cap5 days20 days
Nov 18, 4:15 PM ETPASG
Passage Bio Inc.
Delisting notice
ElevatedForm 8-K
Passage Bio receives Nasdaq notice for stockholders' equity deficiency, plans merger with Remix to cure$13M--